Association between First-Year Virologic Response to Raltegravir and Long-Term Outcomes in Treatment-Experienced Patients with HIV-1 Infection

BACKGROUND: We explored the relationship between virologic response in the first year of treatment and long-term outcomes in the BENCHMRK studies. METHODS: Patients failing ART with 3-class resistant HIV-1 received double-blinded raltegravir (or placebo) with optimized background therapy (OBT) until...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antivir Ther
Autors principals: Eron, Joseph J., Cooper, David A., Steigbigel, Roy T., Clotet, Bonaventura, Yeni, Patrick, Strohmaier, Kim M., Rodgers, Anthony, Barnard, Richard J., Nguyen, Bach-Yen T., Teppler, Hedy
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4422784/
https://ncbi.nlm.nih.gov/pubmed/25350973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2912
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars